INTEGRATED BIOPHARMA INC Number of Reportable Segments
INTEGRATED BIOPHARMA INC (INBP) reported Number of Reportable Segments of 200.00% for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-05-08
- INTEGRATED BIOPHARMA INC number of reportable segments for the quarter ending 2026-03-31 was 200.00%.
- INTEGRATED BIOPHARMA INC number of reportable segments for the quarter ending 2025-09-30 was 200.00%, a 0.00% change year-over-year.
- INTEGRATED BIOPHARMA INC number of reportable segments for the quarter ending 2024-09-30 was 200.00%, a 0.00% change year-over-year.
- INTEGRATED BIOPHARMA INC number of reportable segments for the quarter ending 2023-12-31 was 200.00%.
- INTEGRATED BIOPHARMA INC number of reportable segments for fiscal 2024 was 200.00%, a 0.00% change from fiscal 2023.
- INTEGRATED BIOPHARMA INC number of reportable segments for fiscal 2023 was 200.00%, a 0.00% change from fiscal 2022.
- INTEGRATED BIOPHARMA INC number of reportable segments for fiscal 2022 was 200.00%, a 0.00% change from fiscal 2021.
- INTEGRATED BIOPHARMA INC number of reportable segments for fiscal 2021 was 200.00%, a 0.00% change from fiscal 2020.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month | Number of Reportable Segments 15 month |
|---|---|---|---|---|---|
| 2026-03-31 | 200.00% 10-Q · filed 2026-05-08 | ||||
| 2025-12-31 | 200.00% 10-Q · filed 2026-02-11 | ||||
| 2025-09-30 | 200.00% 10-Q · filed 2025-11-10 | ||||
| 2025-03-31 | 200.00% 10-Q · filed 2025-05-14 | ||||
| 2024-12-31 | 200.00% 10-Q · filed 2025-02-13 | ||||
| 2024-09-30 | 200.00% 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | 200.00% 10-K · filed 2024-09-20 | ||||
| 2024-03-31 | 200.00% 10-Q · filed 2024-05-10 | ||||
| 2023-12-31 | 200.00% 10-Q · filed 2024-02-12 | ||||
| 2023-09-30 | 200.00% 10-Q · filed 2023-11-09 | ||||
| 2023-06-30 | 200.00% 10-K · filed 2023-09-15 | ||||
| 2023-03-31 | 200.00% 10-Q · filed 2023-05-11 | ||||
| 2022-12-31 | 200.00% 10-Q · filed 2023-02-10 | ||||
| 2022-09-30 | 200.00% 10-Q · filed 2022-11-10 | ||||
| 2022-06-30 | 200.00% 10-K · filed 2022-09-13 | ||||
| 2022-03-31 | 200.00% 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | 200.00% 10-Q · filed 2022-02-10 | ||||
| 2021-09-30 | 200.00% 10-Q · filed 2021-11-10 | ||||
| 2021-06-30 | 200.00% 10-K · filed 2021-09-02 | ||||
| 2021-03-31 | 200.00% 10-Q · filed 2021-05-13 | ||||
| 2020-12-31 | 200.00% 10-Q · filed 2021-02-12 | ||||
| 2020-09-30 | 200.00% 10-Q · filed 2020-11-12 | ||||
| 2020-06-30 | 200.00% 10-K · filed 2020-09-23 | ||||
| 2020-03-31 | 300.00% 10-Q · filed 2020-05-13 | ||||
| 2019-12-31 | 300.00% 10-Q · filed 2020-02-12 | ||||
| 2019-09-30 | 300.00% 10-Q · filed 2019-11-13 | ||||
| 2019-06-30 | 300.00% 10-K · filed 2019-08-29 | ||||
| 2019-03-31 | 300.00% 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | 300.00% 10-Q · filed 2019-02-13 | ||||
| 2018-09-30 | 300.00% 10-Q · filed 2018-11-09 | ||||
| 2018-06-30 | 300.00% 10-K · filed 2018-09-12 | ||||
| 2018-03-31 | 300.00% 10-Q · filed 2018-05-09 | ||||
| 2017-12-31 | 300.00% 10-Q · filed 2018-02-09 | ||||
| 2017-09-30 | 300.00% 10-Q · filed 2017-11-09 | ||||
| 2017-06-30 | 300.00% 10-K · filed 2017-09-01 | ||||
| 2017-03-31 | 300.00% 10-Q · filed 2017-05-10 | ||||
| 2016-12-31 | 300.00% 10-Q · filed 2017-02-10 | ||||
| 2016-09-30 | 300.00% 10-Q · filed 2016-11-10 | ||||
| 2016-06-30 | 300.00% 10-K · filed 2016-09-02 | ||||
| 2015-12-31 | 300.00% 10-Q · filed 2016-05-13 | ||||
| 2015-09-30 | 300.00% 10-Q · filed 2015-11-05 | ||||
| 2015-06-30 | 300.00% 10-K · filed 2015-09-04 | ||||
| 2015-03-31 | 300.00% 10-Q · filed 2015-05-14 | ||||
| 2014-12-31 | 300.00% 10-Q · filed 2015-02-17 | ||||
| 2014-09-30 | 300.00% 10-Q · filed 2014-11-07 | ||||
| 2014-06-30 | 300.00% 10-K · filed 2014-09-08 | ||||
| 2014-03-31 | 300.00% 10-Q · filed 2014-05-14 | ||||
| 2013-06-30 | 300.00% 10-K · filed 2013-09-30 |